Global Parkinson's Disease Drug Sales Market Report Forecast 2017-2021

August 2017 | 103 pages | ID: G6E9FCF073EEN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

United States
China
Europe
Japan

The Major players reported in the market include:

Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical
Abbvie
Akorn
Astellas Pharma
Desitin Arzneimittel
Endo International

Product Segment Analysis:

Type 1
Type 2
Type 3

Application Segment Analysis:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 PARKINSON'S DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Classification of Parkinson's Disease Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Parkinson's Disease Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Parkinson's Disease Drug Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Parkinson's Disease Drug (2012-2021)
  1.5.1 Global Parkinson's Disease Drug Sales and Growth Rate (2012-2021)
  1.5.2 Global Parkinson's Disease Drug Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON PARKINSON'S DISEASE DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 PARKINSON'S DISEASE DRUG MANUFACTURING COST ANALYSIS

3.1 Parkinson's Disease Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Parkinson's Disease Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Parkinson's Disease Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL PARKINSON'S DISEASE DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Parkinson's Disease Drug Market Competition by Manufacturers
  5.1.1 Global Parkinson's Disease Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Parkinson's Disease Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Parkinson's Disease Drug (Volume and Value) by Type
  5.5.1 Global Parkinson's Disease Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Parkinson's Disease Drug (Volume and Value) by Regions
  5.3.1 Global Parkinson's Disease Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Parkinson's Disease Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Parkinson's Disease Drug (Volume) by Application

6 UNITED STATES PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Parkinson's Disease Drug Sales and Value (2012-2017)
  6.1.1 United States Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Parkinson's Disease Drug Sales Price Trend (2012-2017)
6.2 United States Parkinson's Disease Drug Sales and Market Share by Manufacturers
6.3 United States Parkinson's Disease Drug Sales and Market Share by Type
6.4 United States Parkinson's Disease Drug Sales and Market Share by Application

7 CHINA PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Parkinson's Disease Drug Sales and Value (2012-2017)
  7.1.1 China Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Parkinson's Disease Drug Sales Price Trend (2012-2017)
7.2 China Parkinson's Disease Drug Sales and Market Share by Manufacturers
7.3 China Parkinson's Disease Drug Sales and Market Share by Type
7.4 China Parkinson's Disease Drug Sales and Market Share by Application

8 EUROPE PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Parkinson's Disease Drug Sales and Value (2012-2017)
  8.1.1 Europe Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Parkinson's Disease Drug Sales Price Trend (2012-2017)
8.2 Europe Parkinson's Disease Drug Sales and Market Share by Manufacturers
8.3 Europe Parkinson's Disease Drug Sales and Market Share by Type
8.4 Europe Parkinson's Disease Drug Sales and Market Share by Application

9 JAPAN PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Parkinson's Disease Drug Sales and Value (2012-2017)
  9.1.1 Japan Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Parkinson's Disease Drug Sales Price Trend (2012-2017)
9.2 Japan Parkinson's Disease Drug Sales and Market Share by Manufacturers
9.3 Japan Parkinson's Disease Drug Sales and Market Share by Type
9.4 Japan Parkinson's Disease Drug Sales and Market Share by Application

10 GLOBAL PARKINSON'S DISEASE DRUG MANUFACTURERS ANALYSIS

10.1 Boehringer Ingelheim
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Novartis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Teva Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Abbvie
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Akorn
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Astellas Pharma
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Desitin Arzneimittel
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Endo International
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL PARKINSON'S DISEASE DRUG MARKET FORECAST (2017-2021)

13.1 Global Parkinson's Disease Drug Sales, Revenue Forecast (2017-2021)
13.2 Global Parkinson's Disease Drug Sales Forecast by Regions (2017-2021)
13.3 Global Parkinson's Disease Drug Sales Forecast by Type (2017-2021)
13.4 Global Parkinson's Disease Drug Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Drug
Table Classification of Parkinson's Disease Drug
Figure Global Sales Market Share of Parkinson's Disease Drug by Type in 2015
Table Applications of Parkinson's Disease Drug
Figure Global Sales Market Share of Parkinson's Disease Drug by Application in 2015
Figure United States Parkinson's Disease Drug Revenue and Growth Rate (2012-2021)
Figure China Parkinson's Disease Drug Revenue and Growth Rate (2012-2021)
Figure Europe Parkinson's Disease Drug Revenue and Growth Rate (2012-2021)
Figure Japan Parkinson's Disease Drug Revenue and Growth Rate (2012-2021)
Figure Global Parkinson's Disease Drug Sales and Growth Rate (2012-2021)
Figure Global Parkinson's Disease Drug Revenue and Growth Rate (2012-2021)
Table Global Parkinson's Disease Drug Sales of Key Manufacturers (2012-2017)
Table Global Parkinson's Disease Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Parkinson's Disease Drug Sales Share by Manufacturers
Figure 2016 Parkinson's Disease Drug Sales Share by Manufacturers
Table Global Parkinson's Disease Drug Revenue by Manufacturers (2012-2017)
Table Global Parkinson's Disease Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table 2016 Global Parkinson's Disease Drug Revenue Share by Manufacturers
Table Global Parkinson's Disease Drug Sales and Market Share by Type (2012-2017)
Table Global Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure Global Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)
Table Global Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
Table Global Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure Global Parkinson's Disease Drug Revenue Growth Rate by Type (2012-2017)
Table Global Parkinson's Disease Drug Sales and Market Share by Regions (2012-2017)
Table Global Parkinson's Disease Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Parkinson's Disease Drug by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Sales Growth Rate by Regions (2012-2017)
Table Global Parkinson's Disease Drug Revenue and Market Share by Regions (2012-2017)
Table Global Parkinson's Disease Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Regions (2012-2017)
Figure Global Parkinson's Disease Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Parkinson's Disease Drug Sales and Market Share by Application (2012-2017)
Table Global Parkinson's Disease Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Parkinson's Disease Drug by Application (2012-2017)
Figure Global Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
Figure United States Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
Figure United States Parkinson's Disease Drug Sales Price Trend (2012-2017)
Table United States Parkinson's Disease Drug Sales by Manufacturers (2012-2017)
Table United States Parkinson's Disease Drug Market Share by Manufacturers (2012-2017)
Table United States Parkinson's Disease Drug Sales by Type (2012-2017)
Table United States Parkinson's Disease Drug Market Share by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales by Application (2012-2017)
Table United States Parkinson's Disease Drug Market Share by Application (2012-2017)
Figure China Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
Figure China Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
Figure China Parkinson's Disease Drug Sales Price Trend (2012-2017)
Table China Parkinson's Disease Drug Sales by Manufacturers (2012-2017)
Table China Parkinson's Disease Drug Market Share by Manufacturers (2012-2017)
Table China Parkinson's Disease Drug Sales by Type (2012-2017)
Table China Parkinson's Disease Drug Market Share by Type (2012-2017)
Table China Parkinson's Disease Drug Sales by Application (2012-2017)
Table China Parkinson's Disease Drug Market Share by Application (2012-2017)
Figure Europe Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
Figure Europe Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
Figure Europe Parkinson's Disease Drug Sales Price Trend (2012-2017)
Table Europe Parkinson's Disease Drug Sales by Manufacturers (2012-2017)
Table Europe Parkinson's Disease Drug Market Share by Manufacturers (2012-2017)
Table Europe Parkinson's Disease Drug Sales by Type (2012-2017)
Table Europe Parkinson's Disease Drug Market Share by Type (2012-2017)
Table Europe Parkinson's Disease Drug Sales by Application (2012-2017)
Table Europe Parkinson's Disease Drug Market Share by Application (2012-2017)
Figure Japan Parkinson's Disease Drug Sales and Growth Rate (2012-2017)
Figure Japan Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
Figure Japan Parkinson's Disease Drug Sales Price Trend (2012-2017)
Table Japan Parkinson's Disease Drug Sales by Manufacturers (2012-2017)
Table Japan Parkinson's Disease Drug Market Share by Manufacturers (2012-2017)
Table Japan Parkinson's Disease Drug Sales by Type (2012-2017)
Table Japan Parkinson's Disease Drug Market Share by Type (2012-2017)
Table Japan Parkinson's Disease Drug Sales by Application (2012-2017)
Table Japan Parkinson's Disease Drug Market Share by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Parkinson's Disease Drug Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Parkinson's Disease Drug Global Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Global Market Share (2012-2017)
Table Abbvie Basic Information List
Table Abbvie Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbvie Parkinson's Disease Drug Global Market Share (2012-2017)
Table Akorn Basic Information List
Table Akorn Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Akorn Parkinson's Disease Drug Global Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Global Market Share (2012-2017)
Table Desitin Arzneimittel Basic Information List
Table Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Global Market Share (2012-2017)
Table Endo International Basic Information List
Table Endo International Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Endo International Parkinson's Disease Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure Global Parkinson's Disease Drug Sales and Growth Rate Forecast (2017-2021)
Figure Global Parkinson's Disease Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Parkinson's Disease Drug Sales Forecast by Regions (2017-2021)
Table Global Parkinson's Disease Drug Sales Forecast by Type (2017-2021)
Table Global Parkinson's Disease Drug Sales Forecast by Application (2017-2021)